Literature DB >> 6486518

High out-put congestive heart failure as first manifestation of Osler-Weber-Rendu disease.

M Montejo Baranda, M Perez, J De Andres, C De la Hoz, J Merino, C Aguirre.   

Abstract

We present two cases of hemorrhagic hereditary telangiectasia (HHT) or Osler-Weber-Rendu disease which started as heart failure. Both had multiple arteriovenous fistulas, one of them in a rare localization in this disease, a lower extremity. We conclude stressing the importance of thinking of HHT in the presence of obscure heart failure or arteriovenous fistulas and of looking for internal fistulas when faced by a HHT.

Entities:  

Mesh：

Year:  1984        PMID： 6486518     DOI： 10.1177/000331978403500904

Source DB:  PubMed          Journal:  Angiology        ISSN： 0003-3197            Impact factor:   3.619


  5 in total

1.  High-output heart failure caused by arteriovenous fistula long after nephrectomy.

Authors:  Kazuyuki Ozaki; Takaaki Kubo; Naoji Hanayama; Katsuharu Hatada; Hisahito Shinagawa; Satoru Maeba; Kazuhiko Hirata; Takanao Aoki; Makoto Kodama; Yoshifusa Aizawa
Journal:  Heart Vessels       Date:  2005-09       Impact factor: 2.037

2.  Transcatheter and percutaneous procedures for huge pelvic arteriovenous malformations causing high-output heart failure.

Authors:  Munemasa Okada; Masatoshi Kato; Kosuke Uchida; Yoko Sufu; Shinichi Okuda; Masafumi Yano; Naofumi Matsunaga
Journal:  J Cardiol Cases       Date:  2015-07-27

Review 3.  Cardiac and Hemodynamic Manifestations of Hereditary Hemorrhagic Telangiectasia.

Authors:  Ahmed Farhan; Muhammad A Latif; Anum Minhas; Clifford R Weiss
Journal:  Int J Angiol       Date:  2022-07-09

Review 4.  Rectal arterio-portal fistula: an unusual cause of persistent bleeding per rectum following a proximal spleno-renal shunt.

Authors:  Hao Yun Yap; Ser Yee Lee; Yaw Fui Alexander Chung; Kiang Hiong Tay; Albert Su-Chong Low; Choon Hua Thng; Krishnakumar Madhavan
Journal:  World J Gastroenterol       Date:  2013-07-07       Impact factor: 5.742

5.  Combination treatment with an erythropoiesis-stimulating agent and intravenous iron alleviates anaemia in patients with hereditary haemorrhagic telangiectasia.

Authors:  Honar Cherif; Torbjörn Karlsson
Journal:  Ups J Med Sci       Date:  2014-09-04       Impact factor: 2.384
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.